Company Filing History:
Years Active: 2017-2018
Title: The Innovative Contributions of Anna K Fulbright
Introduction
Anna K Fulbright is a notable inventor based in Columbia, MD (US). She has made significant contributions to the field of molecular biology, particularly in the detection of HPV nucleic acids. With a total of 2 patents, her work has implications for cancer research and diagnostics.
Latest Patents
Anna's latest patents include "Materials and methods for detection of HPV nucleic acids." This patent provides nucleic acids capable of hybridizing to HPV 16 and/or HPV 18 nucleic acids, specifically mRNA encoding E2 and E6-7 gene products. These nucleic acids are useful in various methods, including isolating RNA from biological samples and predicting the progression of precancerous cervical lesions. Another significant patent is the "Non-target amplification method for detection of RNA splice-forms in a sample." This patent outlines methods for isolating RNA and determining the presence of specific RNA splice-form variants in biological samples.
Career Highlights
Anna K Fulbright is currently associated with Qiagen Gaithersburg Inc., where she continues to advance her research in molecular diagnostics. Her work is pivotal in developing innovative solutions for detecting and understanding HPV-related health issues.
Collaborations
Throughout her career, Anna has collaborated with esteemed colleagues, including Brian Lowe and Irina A Nazarenko. These collaborations have further enriched her research and contributed to her success as an inventor.
Conclusion
Anna K Fulbright's contributions to the field of molecular biology and her innovative patents highlight her role as a leading inventor in the detection of HPV nucleic acids. Her work not only advances scientific knowledge but also has the potential to improve health outcomes for many individuals.